Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) Interest & Investment Income (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Interest & Investment Income data on record, last reported at $6.0 million in Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 20.0% year-over-year to $6.0 million; the TTM value through Dec 2025 reached $22.0 million, down 4.35%, while the annual FY2025 figure was $22.0 million, 4.35% down from the prior year.
  • Interest & Investment Income reached $6.0 million in Q4 2025 per INDV's latest filing, roughly flat from $6.0 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $7.0 million in Q1 2024 and bottomed at $4.0 million in Q1 2025.